Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 284

1.

Serum metabolites associated with dietary protein intake: results from the Modification of Diet in Renal Disease (MDRD) randomized clinical trial.

Rebholz CM, Zheng Z, Grams ME, Appel LJ, Sarnak MJ, Inker LA, Levey AS, Coresh J.

Am J Clin Nutr. 2019 Feb 8. doi: 10.1093/ajcn/nqy202. [Epub ahead of print]

PMID:
30753252
2.

Serum Metabolomic Alterations Associated with Proteinuria in CKD.

Luo S, Coresh J, Tin A, Rebholz CM, Appel LJ, Chen J, Vasan RS, Anderson AH, Feldman HI, Kimmel PL, Waikar SS, Köttgen A, Evans AM, Levey AS, Inker LA, Sarnak MJ, Grams ME; Chronic Kidney Disease Biomarkers Consortium Investigators.

Clin J Am Soc Nephrol. 2019 Feb 7. pii: CJN.10010818. doi: 10.2215/CJN.10010818. [Epub ahead of print]

PMID:
30733224
3.

Change in albuminuria and subsequent risk of end-stage kidney disease: an individual participant-level consortium meta-analysis of observational studies.

Coresh J, Heerspink HJL, Sang Y, Matsushita K, Arnlov J, Astor BC, Black C, Brunskill NJ, Carrero JJ, Feldman HI, Fox CS, Inker LA, Ishani A, Ito S, Jassal S, Konta T, Polkinghorne K, Romundstad S, Solbu MD, Stempniewicz N, Stengel B, Tonelli M, Umesawa M, Waikar SS, Wen CP, Wetzels JFM, Woodward M, Grams ME, Kovesdy CP, Levey AS, Gansevoort RT; Chronic Kidney Disease Prognosis Consortium and Chronic Kidney Disease Epidemiology Collaboration.

Lancet Diabetes Endocrinol. 2019 Feb;7(2):115-127. doi: 10.1016/S2213-8587(18)30313-9. Epub 2019 Jan 8.

PMID:
30635225
4.

Erratum: Evans M, Grams ME, Sang Y, et al., for the Chronic Kidney Disease Prognosis Consortium. Risk factors for prognosis in patients with severely decreased GFR. Kidney Int Rep. 2018;3:625-637.

Chronic Kidney Disease Prognosis Consortium.

Kidney Int Rep. 2018 Aug 30;3(6):1506. doi: 10.1016/j.ekir.2018.08.009. eCollection 2018 Nov.

5.

PTH, FGF23, and Intensive Blood Pressure Lowering in Chronic Kidney Disease Participants in SPRINT.

Ginsberg C, Craven TE, Chonchol MB, Cheung AK, Sarnak MJ, Ambrosius WT, Killeen AA, Raphael KL, Bhatt UY, Chen J, Chertow GM, Freedman BI, Oparil S, Papademetriou V, Wall BM, Wright CB, Ix JH, Shlipak MG; SPRINT Research Group.

Clin J Am Soc Nephrol. 2018 Dec 7;13(12):1816-1824. doi: 10.2215/CJN.05390518. Epub 2018 Nov 13.

PMID:
30425104
6.

Kidney Function and Hospital-Acquired Infections: Worth a Deeper Look.

Wright S, Doron S, Sarnak MJ.

Am J Kidney Dis. 2019 Jan;73(1):1-3. doi: 10.1053/j.ajkd.2018.08.019. Epub 2018 Nov 10. No abstract available.

PMID:
30424916
7.

Blood pressure target for the dialysis patient.

McCallum W, Sarnak MJ.

Semin Dial. 2019 Jan;32(1):35-40. doi: 10.1111/sdi.12754. Epub 2018 Nov 13. Review.

PMID:
30422343
8.

Kidney Damage Biomarkers and Incident Chronic Kidney Disease During Blood Pressure Reduction: A Case-Control Study.

Zhang WR, Craven TE, Malhotra R, Cheung AK, Chonchol M, Drawz P, Sarnak MJ, Parikh CR, Shlipak MG, Ix JH; SPRINT Research Group.

Ann Intern Med. 2018 Nov 6;169(9):610-618. doi: 10.7326/M18-1037. Epub 2018 Oct 23.

PMID:
30357395
10.

Acute Declines in Renal Function during Intensive BP Lowering and Long-Term Risk of Death.

Ku E, Ix JH, Jamerson K, Tangri N, Lin F, Gassman J, Smogorzewski M, Sarnak MJ.

J Am Soc Nephrol. 2018 Sep;29(9):2401-2408. doi: 10.1681/ASN.2018040365. Epub 2018 Jul 13.

PMID:
30006417
11.

Serum Calcitriol Concentrations and Kidney Function Decline, Heart Failure, and Mortality in Elderly Community-Living Adults: The Health, Aging, and Body Composition Study.

Selamet U, Katz R, Ginsberg C, Rifkin DE, Fried LF, Kritchevsky SB, Hoofnagle AN, Bibbins-Domingo K, Drew D, Harris T, Newman A, Gutiérrez OM, Sarnak MJ, Shlipak MG, Ix JH.

Am J Kidney Dis. 2018 Sep;72(3):419-428. doi: 10.1053/j.ajkd.2018.03.026. Epub 2018 Jun 6.

PMID:
29885925
12.

Serum metabolites are associated with all-cause mortality in chronic kidney disease.

Hu JR, Coresh J, Inker LA, Levey AS, Zheng Z, Rebholz CM, Tin A, Appel LJ, Chen J, Sarnak MJ, Grams ME.

Kidney Int. 2018 Aug;94(2):381-389. doi: 10.1016/j.kint.2018.03.008. Epub 2018 Jun 2.

PMID:
29871777
13.

Intensive Blood Pressure Targets and Kidney Disease.

Chang TI, Sarnak MJ.

Clin J Am Soc Nephrol. 2018 Oct 8;13(10):1575-1577. doi: 10.2215/CJN.02010218. Epub 2018 May 24. No abstract available.

PMID:
29798887
14.

Serum 6-Bromotryptophan Levels Identified as a Risk Factor for CKD Progression.

Tin A, Nadkarni G, Evans AM, Winkler CA, Bottinger E, Rebholz CM, Sarnak MJ, Inker LA, Levey AS, Lipkowitz MS, Appel LJ, Arking DE, Coresh J, Grams ME.

J Am Soc Nephrol. 2018 Jul;29(7):1939-1947. doi: 10.1681/ASN.2017101064. Epub 2018 May 18.

PMID:
29777021
15.

Chronic kidney disease and peripheral nerve function in the Health, Aging and Body Composition Study.

Moorthi RN, Doshi S, Fried LF, Moe SM, Sarnak MJ, Satterfield S, Schwartz AV, Shlipak M, Lange-Maia BS, Harris TB, Newman AB, Strotmeyer ES.

Nephrol Dial Transplant. 2018 May 10. doi: 10.1093/ndt/gfy102. [Epub ahead of print]

PMID:
29757410
16.

Low thyroid function is not associated with an accelerated deterioration in renal function.

Meuwese CL, van Diepen M, Cappola AR, Sarnak MJ, Shlipak MG, Bauer DC, Fried LP, Iacoviello M, Vaes B, Degryse J, Khaw KT, Luben RN, Åsvold BO, Bjøro T, Vatten LJ, de Craen AJM, Trompet S, Iervasi G, Molinaro S, Ceresini G, Ferrucci L, Dullaart RPF, Bakker SJL, Jukema JW, Kearney PM, Stott DJ, Peeters RP, Franco OH, Völzke H, Walsh JP, Bremner A, Sgarbi JA, Maciel RMB, Imaizumi M, Ohishi W, Dekker FW, Rodondi N, Gussekloo J, den Elzen WPJ; Thyroid Studies Collaboration.

Nephrol Dial Transplant. 2018 Apr 18. doi: 10.1093/ndt/gfy071. [Epub ahead of print]

PMID:
29684213
17.

Fibroblast Growth Factor 23: A Biomarker of Kidney Function Decline.

Drew DA, Katz R, Kritchevsky S, Ix JH, Shlipak MG, Newman AB, Hoofnagle A, Fried L, Sarnak MJ, Gutierrez OM.

Am J Nephrol. 2018;47(4):242-250. doi: 10.1159/000488361. Epub 2018 Apr 5.

PMID:
29621752
18.

Urinary Biomarkers of Kidney Tubular Damage and Risk of Cardiovascular Disease and Mortality in Elders.

Jotwani V, Katz R, Ix JH, Gutiérrez OM, Bennett M, Parikh CR, Cummings SR, Sarnak MJ, Shlipak MG.

Am J Kidney Dis. 2018 Aug;72(2):205-213. doi: 10.1053/j.ajkd.2017.12.013. Epub 2018 Mar 27.

PMID:
29602632
19.

Serum albumin concentration and risk of end-stage renal disease: the REGARDS study.

Walther CP, Gutiérrez OM, Cushman M, Judd SE, Lang J, McClellan W, Muntner P, Sarnak MJ, Shlipak MG, Warnock DG, Katz R, Ix JH.

Nephrol Dial Transplant. 2018 Oct 1;33(10):1770-1777. doi: 10.1093/ndt/gfx331.

PMID:
29281114
20.

Relationship of acid-base status with arterial stiffness in community-living elders: the Health ABC Study.

Chen W, Newman AB, Fried LF, Rifkin DE, Shlipak MG, Sarnak MJ, Katz R, Madero M, Raphael KL, Bushinsky DA, Ix JH.

Nephrol Dial Transplant. 2018 Sep 1;33(9):1572-1579. doi: 10.1093/ndt/gfx292.

PMID:
29177410
21.

The 24,25 to 25-hydroxyvitamin D ratio and fracture risk in older adults: The cardiovascular health study.

Ginsberg C, Katz R, de Boer IH, Kestenbaum BR, Chonchol M, Shlipak MG, Sarnak MJ, Hoofnagle AN, Rifkin DE, Garimella PS, Ix JH.

Bone. 2018 Feb;107:124-130. doi: 10.1016/j.bone.2017.11.011. Epub 2017 Nov 16.

22.

Discrepancies between Perceived and Measured Cognition in Kidney Transplant Recipients: Implications for Clinical Management.

Gupta A, Thomas TS, Klein JA, Montgomery RN, Mahnken JD, Johnson DK, Drew DA, Sarnak MJ, Burns JM.

Nephron. 2018;138(1):22-28. doi: 10.1159/000481182. Epub 2017 Oct 20.

23.

Association of serum albumin levels with kidney function decline and incident chronic kidney disease in elders.

Lang J, Katz R, Ix JH, Gutierrez OM, Peralta CA, Parikh CR, Satterfield S, Petrovic S, Devarajan P, Bennett M, Fried LF, Cummings SR, Sarnak MJ, Shlipak MG.

Nephrol Dial Transplant. 2018 Jun 1;33(6):986-992. doi: 10.1093/ndt/gfx229.

PMID:
28992097
24.

Metabolomic Alterations Associated with Cause of CKD.

Grams ME, Tin A, Rebholz CM, Shafi T, Köttgen A, Perrone RD, Sarnak MJ, Inker LA, Levey AS, Coresh J.

Clin J Am Soc Nephrol. 2017 Nov 7;12(11):1787-1794. doi: 10.2215/CJN.02560317. Epub 2017 Sep 28.

25.

Oral Anticoagulants to Prevent Stroke in Nonvalvular Atrial Fibrillation in Patients With CKD Stage 5D: An NKF-KDOQI Controversies Report.

Bansal VK, Herzog CA, Sarnak MJ, Choi MJ, Mehta R, Jaar BG, Rocco MV, Kramer H.

Am J Kidney Dis. 2017 Dec;70(6):859-868. doi: 10.1053/j.ajkd.2017.08.003. Epub 2017 Sep 21.

PMID:
28941763
26.

eGFR and Albuminuria in Relation to Risk of Incident Atrial Fibrillation: A Meta-Analysis of the Jackson Heart Study, the Multi-Ethnic Study of Atherosclerosis, and the Cardiovascular Health Study.

Bansal N, Zelnick LR, Alonso A, Benjamin EJ, de Boer IH, Deo R, Katz R, Kestenbaum B, Mathew J, Robinson-Cohen C, Sarnak MJ, Shlipak MG, Sotoodehnia N, Young B, Heckbert SR.

Clin J Am Soc Nephrol. 2017 Sep 7;12(9):1386-1398. doi: 10.2215/CJN.01860217. Epub 2017 Aug 10.

27.

White matter damage in maintenance hemodialysis patients: a diffusion tensor imaging study.

Drew DA, Koo BB, Bhadelia R, Weiner DE, Duncan S, la Garza MM, Gupta A, Tighiouart H, Scott T, Sarnak MJ.

BMC Nephrol. 2017 Jul 5;18(1):213. doi: 10.1186/s12882-017-0628-0.

28.

Risk of ESRD and Mortality Associated With Change in Filtration Markers.

Rebholz CM, Inker LA, Chen Y, Liang M, Foster MC, Eckfeldt JH, Kimmel PL, Vasan RS, Feldman HI, Sarnak MJ, Hsu CY, Levey AS, Coresh J; Chronic Kidney Disease Biomarkers Consortium.

Am J Kidney Dis. 2017 Oct;70(4):551-560. doi: 10.1053/j.ajkd.2017.04.025. Epub 2017 Jun 23.

29.

Epidemiology: The global burden of reduced GFR: ESRD, CVD and mortality.

Sharma S, Sarnak MJ.

Nat Rev Nephrol. 2017 Aug;13(8):447-448. doi: 10.1038/nrneph.2017.84. Epub 2017 Jun 19. No abstract available.

PMID:
28626221
30.

Prevalence and correlates of cognitive impairment in kidney transplant recipients.

Gupta A, Mahnken JD, Johnson DK, Thomas TS, Subramaniam D, Polshak T, Gani I, John Chen G, Burns JM, Sarnak MJ.

BMC Nephrol. 2017 May 12;18(1):158. doi: 10.1186/s12882-017-0570-1.

31.

Acute Declines in Renal Function during Intensive BP Lowering: Implications for Future ESRD Risk.

Ku E, Bakris G, Johansen KL, Lin F, Sarnak MJ, Campese VM, Jamerson K, Gassman JJ, Smogorzewski M, Hsu CY.

J Am Soc Nephrol. 2017 Sep;28(9):2794-2801. doi: 10.1681/ASN.2017010040. Epub 2017 May 4.

32.

Association of Blood Pressure Trajectory With Mortality, Incident Cardiovascular Disease, and Heart Failure in the Cardiovascular Health Study.

Smitson CC, Scherzer R, Shlipak MG, Psaty BM, Newman AB, Sarnak MJ, Odden MC, Peralta CA.

Am J Hypertens. 2017 Jun 1;30(6):587-593. doi: 10.1093/ajh/hpx028.

33.

Association of urinary uromodulin with kidney function decline and mortality: the health ABC study
.

Garimella PS, Katz R, Ix JH, Fried LF, Kritchevsky SB, Devarajan P, Bennett MR, Parikh CR, Shlipak MG, Harris TB, Gutiérrez OM, Sarnak MJ.

Clin Nephrol. 2017 Jun;87(6):278-286. doi: 10.5414/CN109005.

34.

The Relation of Serum Potassium Concentration with Cardiovascular Events and Mortality in Community-Living Individuals.

Hughes-Austin JM, Rifkin DE, Beben T, Katz R, Sarnak MJ, Deo R, Hoofnagle AN, Homma S, Siscovick DS, Sotoodehnia N, Psaty BM, de Boer IH, Kestenbaum B, Shlipak MG, Ix JH.

Clin J Am Soc Nephrol. 2017 Feb 7;12(2):245-252. doi: 10.2215/CJN.06290616. Epub 2017 Jan 31.

35.

Cognitive Decline and Its Risk Factors in Prevalent Hemodialysis Patients.

Drew DA, Weiner DE, Tighiouart H, Duncan S, Gupta A, Scott T, Sarnak MJ.

Am J Kidney Dis. 2017 Jun;69(6):780-787. doi: 10.1053/j.ajkd.2016.11.015. Epub 2017 Jan 26.

36.

Urinary Uromodulin and Risk of Urinary Tract Infections: The Cardiovascular Health Study.

Garimella PS, Bartz TM, Ix JH, Chonchol M, Shlipak MG, Devarajan P, Bennett MR, Sarnak MJ.

Am J Kidney Dis. 2017 Jun;69(6):744-751. doi: 10.1053/j.ajkd.2016.08.022. Epub 2016 Oct 28.

37.

Absolute Rates of Heart Failure, Coronary Heart Disease, and Stroke in Chronic Kidney Disease: An Analysis of 3 Community-Based Cohort Studies.

Bansal N, Katz R, Robinson-Cohen C, Odden MC, Dalrymple L, Shlipak MG, Sarnak MJ, Siscovick DS, Zelnick L, Psaty BM, Kestenbaum B, Correa A, Afkarian M, Young B, de Boer IH.

JAMA Cardiol. 2017 Mar 1;2(3):314-318. doi: 10.1001/jamacardio.2016.4652.

38.

Association between chronic kidney disease and cancer mortality: A report from the ALLHAT.

Chen DP, Davis BR, Simpson LM, Cushman WC, Cutler JA, Dobre M, Ford CE, Louis GT, Muntner P, Oparil S, Piller LB, Pressel SL, Sarnak MJ, Whelton PK, Wright JT, Rahman M.

Clin Nephrol. 2017 Jan;87 (2017)(1):11-20.

PMID:
27900942
39.

Uromodulin in kidney health and disease.

Garimella PS, Sarnak MJ.

Curr Opin Nephrol Hypertens. 2017 Mar;26(2):136-142. doi: 10.1097/MNH.0000000000000299. Review.

PMID:
27898524
40.

Association of Preoperative Urinary Uromodulin with AKI after Cardiac Surgery.

Garimella PS, Jaber BL, Tighiouart H, Liangos O, Bennett MR, Devarajan P, El-Achkar TM, Sarnak MJ.

Clin J Am Soc Nephrol. 2017 Jan 6;12(1):10-18. doi: 10.2215/CJN.02520316. Epub 2016 Oct 26.

41.

Don't Pass the Salt: Evidence to Support Avoidance of High Salt Intake in CKD.

Leonberg-Yoo AK, Sarnak MJ.

Am J Kidney Dis. 2017 Feb;69(2):175-178. doi: 10.1053/j.ajkd.2016.09.008. Epub 2016 Oct 24. No abstract available.

42.

Chronic Kidney Disease Progression and Cardiovascular Outcomes Following Cardiac Catheterization-A Population-Controlled Study.

Brown JR, Solomon RJ, Robey RB, Plomondon ME, Maddox TM, Marshall EJ, Nichols EL, Matheny ME, Tsai TT, Rumsfeld JS, Lee RE, Sarnak MJ.

J Am Heart Assoc. 2016 Oct 14;5(10). pii: e003812.

43.

BP Control and Long-Term Risk of ESRD and Mortality.

Ku E, Gassman J, Appel LJ, Smogorzewski M, Sarnak MJ, Glidden DV, Bakris G, Gutiérrez OM, Hebert LA, Ix JH, Lea J, Lipkowitz MS, Norris K, Ploth D, Pogue VA, Rostand SG, Siew ED, Sika M, Tisher CC, Toto R, Wright JT Jr, Wyatt C, Hsu CY.

J Am Soc Nephrol. 2017 Feb;28(2):671-677. doi: 10.1681/ASN.2016030326. Epub 2016 Aug 11.

44.

Urine Potassium Excretion, Kidney Failure, and Mortality in CKD.

Leonberg-Yoo AK, Tighiouart H, Levey AS, Beck GJ, Sarnak MJ.

Am J Kidney Dis. 2017 Mar;69(3):341-349. doi: 10.1053/j.ajkd.2016.03.431. Epub 2016 May 24.

45.

Pericarditis and Pericardial Effusions in End-Stage Renal Disease.

Dad T, Sarnak MJ.

Semin Dial. 2016 Sep;29(5):366-73. doi: 10.1111/sdi.12517. Epub 2016 May 26. Review.

PMID:
27228946
46.

Sleepless in CKD: a novel risk factor for CKD progression?

Sarnak MJ, Unruh M.

Kidney Int. 2016 Jun;89(6):1187-8. doi: 10.1016/j.kint.2016.02.028.

PMID:
27181774
47.

Reduced Mortality Associated with Acute Kidney Injury Requiring Dialysis in the United States.

Brown JR, Rezaee ME, Hisey WM, Cox KC, Matheny ME, Sarnak MJ.

Am J Nephrol. 2016;43(4):261-70. doi: 10.1159/000445846. Epub 2016 Apr 29.

48.

Fibroblast Growth Factor-23 and Frailty in Elderly Community-Dwelling Individuals: The Cardiovascular Health Study.

Beben T, Ix JH, Shlipak MG, Sarnak MJ, Fried LF, Hoofnagle AN, Chonchol M, Kestenbaum BR, de Boer IH, Rifkin DE.

J Am Geriatr Soc. 2016 Feb;64(2):270-6. doi: 10.1111/jgs.13951.

49.

Galectin-3 and Soluble ST2 and Kidney Function Decline in Older Adults: The Cardiovascular Health Study (CHS).

Bansal N, Katz R, Seliger S, DeFilippi C, Sarnak MJ, Delaney JA, Christenson R, de Boer IH, Kestenbaum B, Robinson-Cohen C, Ix JH, Shlipak MG.

Am J Kidney Dis. 2016 Jun;67(6):994-6. doi: 10.1053/j.ajkd.2015.12.022. Epub 2016 Jan 29. No abstract available.

PMID:
26830253
50.

Bicarbonate Concentration, Acid-Base Status, and Mortality in the Health, Aging, and Body Composition Study.

Raphael KL, Murphy RA, Shlipak MG, Satterfield S, Huston HK, Sebastian A, Sellmeyer DE, Patel KV, Newman AB, Sarnak MJ, Ix JH, Fried LF; Health ABC Study.

Clin J Am Soc Nephrol. 2016 Feb 5;11(2):308-16. doi: 10.2215/CJN.06200615. Epub 2016 Jan 14.

Supplemental Content

Loading ...
Support Center